SCHEMBL18558259

SCHEMBL18558259

O=C(/N=C(/Nc1cc(C(F)(F)F)n[nH]1)NC1CCC(O)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
CHEK1 O14757 3/20 0.34
MCHR1 Q99705 3/20 0.34
TRPV1 Q8NER1 2/20 0.34
KCNH2 Q12809 4/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
DPP4 P27487 3/20 0.34
DPP7 Q9UHL4 3/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18558524 0.93 MEN1 (0.35) CHEK1TRPV1MEN1ALDH1A1KMT2A
SCHEMBL9920869 0.93 NPC1 (0.42) TAS1R3TAS1R1TAS1R2KCNH2DPP4
SCHEMBL9920911 0.93 NPC1 (0.39) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL9921132 0.90 HDAC4 (0.40) TAS1R3TAS1R1TAS1R2KCNQ3KCNQ2
SCHEMBL19362654 0.89 TRPV1 (0.42) CHEK1TRPV1KCNH2CCNA2CDK2
SCHEMBL9921119 0.86 MAPK1 (0.39) KCNH2NPC1RAB9AHDAC4HTR2B
SCHEMBL9920822 0.85 HDAC6 (0.36) TRPV1MEN1ALDH1A1KMT2ACCNA2
SCHEMBL9920885 0.85 ACKR3 (0.37) MEN1ALDH1A1KMT2ANPC1RAB9A
SCHEMBL9921133 0.85 GSK3B (0.39) KCNH2NPC1RAB9ASMN1; SMN2HDAC4
SCHEMBL9921025 0.83 HDAC6 (0.39) TRPV1KCNH2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580388-B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2017-02-28 US disclosed